Literature DB >> 17365853

Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma.

Javier De Castro1, Angel Hernández-Hernández, Marina C Rodríguez, José L Sardina, Marcial Llanillo, Jesús Sánchez-Yagüe.   

Abstract

OBJECTIVE: To analyse and compare the phospholipid and fatty acid composition of total lipids and the occurrence of lipid peroxidation and protein oxidation directly in erythrocytes or platelets from chronic obstructive pulmonary disease (COPD) and asthma patients. PATIENTS: Fifteen consecutive outpatients with COPD (all smokers) and asthma (non-smokers) recruited during a moderate-to-severe (COPD) or moderate (asthma) exacerbation. Fifteen subjects with smoking habits similar to those of COPD patients were studied as a control group.
METHODS: Phospholipid and total fatty acid compositions were analysed by two-dimensional thin layer chromatography or gas chromatography-mass spectrometry, respectively. The lipid fluorescence of lipid extracts was measured by spectrofluorimetry. Protein carbonyl contents and profiles were measured by immunoblot detection.
RESULTS: No differences were found either in erythrocyte or platelet cholesterol or phospholipid levels. Only a decrease in the content of phosphatidylserine + phosphatidylinositol (P<0.003) was detected in platelets from the asthma patients. In erythrocytes, the fatty acid profile changed in both lung pathologies, especially as regards polyunsaturated fatty acids (decreases in arachidonic and 22:4 fatty acid contents). Other observed changes were: COPD, an increase in palmitic fatty acid; asthma, an increase in oleic and decreases in eicosapentaenoic and 22:6 + 24:1 fatty acids. In platelets, the fatty acid profiles revealed many differences between both lung pathologies: COPD, a decrease in 18:1 and increases in 20:5 and 22:5 + 24:0; asthma, a decrease in 20:4 and increase in 22:6 + 24:1. In COPD vs. asthma patients, fatty acid changes were mainly detected in platelets, especially in 18-carbon species, with decreases in stearic and 18:1 fatty acids in the COPD patients. Protein oxidation levels were increased in both lung pathologies in both erythrocytes and platelets.
CONCLUSIONS: COPD and asthma are associated with common or specific changes in the lipid composition of erythrocytes and/or platelets. The data point to lipid peroxidation and protein oxidation phenomena in both types of blood cell, although platelets would be more susceptible to stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17365853     DOI: 10.1080/09537100600800776

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  12 in total

Review 1.  Mitochondria in lung disease.

Authors:  Suzanne M Cloonan; Augustine M K Choi
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

Review 2.  Platelet and red blood cell interactions and their role in rheumatoid arthritis.

Authors:  Oore-Ofe O Olumuyiwa-Akeredolu; Etheresia Pretorius
Journal:  Rheumatol Int       Date:  2015-06-10       Impact factor: 2.631

Review 3.  Quenching the fires: Pro-resolving mediators, air pollution, and smoking.

Authors:  Thomas H Thatcher; Collynn F Woeller; Claire E McCarthy; Patricia J Sime
Journal:  Pharmacol Ther       Date:  2019-02-10       Impact factor: 12.310

4.  Identification of potential erythrocyte phospholipid fatty acid biomarkers of advanced lung adenocarcinoma, squamous cell lung carcinoma, and small cell lung cancer.

Authors:  Patricia Sánchez-Rodríguez; Marina C Rodríguez; Jesús Sánchez-Yagüe
Journal:  Tumour Biol       Date:  2015-02-22

5.  Influence of a moderate physical activity intervention on red cell deformability in patients suffering from chronic obstructive pulmonary disease (COPD).

Authors:  Basit Ahmad; Nina Ferrari; Georgina Montiel; Wilhelm Bloch; Anke Raabe-Oetker; Nina Skrobala; Klara Brixius
Journal:  Wien Med Wochenschr       Date:  2013-02-20

6.  Oxidant-antioxidant status in the blood of horses with symptomatic recurrent airway obstruction (RAO).

Authors:  A Niedzwiedz; Z Jaworski
Journal:  J Vet Intern Med       Date:  2014-09-17       Impact factor: 3.333

7.  Modification of the fatty acid composition of the erythrocyte membrane in patients with chronic respiratory diseases.

Authors:  Tatyana P Novgorodtseva; Yulia K Denisenko; Natalia V Zhukova; Marina V Antonyuk; Vera V Knyshova; Tatyana A Gvozdenko
Journal:  Lipids Health Dis       Date:  2013-07-30       Impact factor: 3.876

8.  Oxidant-antioxidant balance in the blood of patients with chronic obstructive pulmonary disease after smoking cessation.

Authors:  Alina Woźniak; Dariusz Górecki; Michał Szpinda; Celestyna Mila-Kierzenkowska; Bartosz Woźniak
Journal:  Oxid Med Cell Longev       Date:  2013-09-05       Impact factor: 6.543

9.  Arachidonic acid intake and asthma risk in children and adults: a systematic review of observational studies.

Authors:  Saki Kakutani; Kahori Egawa; Kayo Saito; Toshihide Suzuki; Chika Horikawa; Tomohiro Rogi; Hiroshi Kawashima; Hiroshi Shibata; Satoshi Sasaki
Journal:  J Nutr Sci       Date:  2014-05-07

10.  Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Bjoern Titz; Karsta Luettich; Patrice Leroy; Stephanie Boue; Gregory Vuillaume; Terhi Vihervaara; Kim Ekroos; Florian Martin; Manuel C Peitsch; Julia Hoeng
Journal:  Int J Mol Sci       Date:  2016-09-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.